Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy
<p dir="ltr">Metformin, the most widely used anti-diabetic drug, also exhibits anti-cancer properties; however, the true potential of metformin as an anticancer drug remains largely unknown. In this study using mouse microvascular endothelial cells (MMECs), we investigated the effect...
محفوظ في:
| المؤلف الرئيسي: | Samson Mathews Samuel (18808246) (author) |
|---|---|
| مؤلفون آخرون: | Noothan Jyothi Satheesh (18808249) (author), Suparna Ghosh (9698402) (author), Dietrich Büsselberg (11008857) (author), Yasser Majeed (9417974) (author), Hong Ding (135247) (author), Chris R. Triggle (4278688) (author) |
| منشور في: |
2019
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
حسب: Samson Samuel (6828956)
منشور في: (2019) -
Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
حسب: Elizabeth Varghese (11008845)
منشور في: (2020) -
Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy
حسب: Samson Mathews Samuel (11008848)
منشور في: (2023) -
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
حسب: Kheraldine, Hadeel
منشور في: (2025) -
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
حسب: Samson Mathews Samuel (11008848)
منشور في: (2020)